Trial · NCT02338973
Outcomes31
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 31
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number and Severity of IP-related AEs | Study duration, up to 52 weeks | adverse events related to IP | NUMBER | |
| PRIMARY | Number of Participants Who Withdrew | Study duration, up to 52 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | Day 1 | BCVA values are presented for Baseline and Day 1 and the change at Day 1 from Baseline for each participant (study and fellow eye). | letters read | NUMBER |
| SECONDARY | Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 2 | Day 2 | BCVA values are presented for Baseline and Day 2 and the change at Day 2 from Baseline for each participant (study and fellow eye). | letters read | NUMBER |
| SECONDARY | Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 3 | Day 3 | BCVA values are presented for Baseline and Day 3 and the change at Day 3 from Baseline for each participant (study and fellow eye). | letters read | NUMBER |
| SECONDARY | Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Week 2 | Week 2 | BCVA values are presented for Baseline and Week 2 and the change at Week 2 from Baseline for each participant (study and fellow eye). | letters read | NUMBER |
| SECONDARY | Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Week 5 | Week 5 | BCVA values are presented for Baseline and Week 5 and the change at Week 5 from Baseline for each participant (study and fellow eye). | letters read | NUMBER |
| SECONDARY | Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Week 8 | Week 8 | BCVA values are presented for Baseline and Week 8 and the change at Week 8 from Baseline for each participant (study and fellow eye). | letters read | NUMBER |
| SECONDARY | Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Week 52 | Week 52 | BCVA values are presented for Baseline and Week 52 and the change at Week 52 from Baseline for each participant (study and fellow eye). | letters read | NUMBER |
| SECONDARY | Change in Maximum Subretinal Fluid Volume From Baseline as Compared to Day 1 | Day 1 | Subretinal Fluid Volume values are presented for Baseline and Day 1 and the change at Day 1 from Baseline for each participant (study and fellow eye). | mm^3 | NUMBER |
| SECONDARY | Change in Maximum Subretinal Fluid Volume From Baseline as Compared to Day 2 | Day 2 | Subretinal Fluid Volume values are presented for Baseline and Day 2 and the change at Day 2 from Baseline for each participant (study and fellow eye). | mm^3 | NUMBER |
| SECONDARY | Change in Maximum Subretinal Fluid Volume From Baseline as Compared to Day 3 | Day 3 | Subretinal Fluid Volume values are presented for Baseline and Day 3 and the change at Day 3 from Baseline for each participant (study and fellow eye). | mm^3 | NUMBER |
| SECONDARY | Change in Maximum Subretinal Fluid Volume From Baseline as Compared to Week 2 | Week 2 | Subretinal Fluid Volume values are presented for Baseline and Week 2 and the change at Week 2 from Baseline for each participant (study and fellow eye). | mm^3 | NUMBER |
| SECONDARY | Change in Maximum Subretinal Fluid Volume From Baseline as Compared to Week 5 | Week 5 | Subretinal Fluid Volume values are presented for Baseline and Week 5 and the change at Week 5 from Baseline for each participant (study and fellow eye). | mm^3 | NUMBER |
| SECONDARY | Change in Maximum Subretinal Fluid Volume From Baseline as Compared to Week 8 | Week 8 | Subretinal Fluid Volume values are presented for Baseline and Week 8 and the change at Week 8 from Baseline for each participant (study and fellow eye). | mm^3 | NUMBER |
| SECONDARY | Change in Maximum Subretinal Fluid Volume From Baseline as Compared to Week 52 | Week 52 | Subretinal Fluid Volume values are presented for Baseline and Week 52 and the change at Week 52 from Baseline for each participant (study and fellow eye). | mm^3 | NUMBER |
| SECONDARY | Change in Central Retinal Thickness as Measured on Cirrus OCT From Baseline as Compared to Day 1 | Day 1 | Central Retinal Thickness values are presented for Baseline and Day 1 and the change at Day 1 from Baseline for each participant (study and fellow eye). | μm | NUMBER |
| SECONDARY | Change in Central Retinal Thickness as Measured on Cirrus OCT From Baseline as Compared to Day 2 | Day 2 | Cirrus OCT values are presented for Baseline and Day 2 and the change at Day 2 from Baseline for each participant (study and fellow eye). | μm | NUMBER |
| SECONDARY | Change in Central Retinal Thickness as Measured on Cirrus OCT From Baseline as Compared to Day 3 | Day 3 | Cirrus OCT values are presented for Baseline and Day 3 and the change at Day 3 from Baseline for each participant (study and fellow eye). | μm | NUMBER |
| SECONDARY | Change in Central Retinal Thickness as Measured on Cirrus OCT From Baseline as Compared to Week 2 | Week 2 | Cirrus OCT values are presented for Baseline and Week 2 and the change at Week 2 from Baseline for each participant (study and fellow eye). | μm | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02338973/outcomes